Daily Archives: September 18, 2020

Imperial Capital Expands Emerging Markets Sales with the Hiring of Erik Hammes

LOS ANGELES, Sept. 18, 2020 (GLOBE NEWSWIRE) — Imperial Capital, LLC (“Imperial Capital”), announced today the continued growth of its dedicated Emerging Markets Sales and Trading Group with the hiring of senior sales professional, Erik Hammes.  Erik joins Imperial Capital in Stamford, CT where the Company has been adding key credit sales and trading talent

PRA Health Sciences and Deep Lens announce strategic relationship to accelerate patient recruitment for precision cancer trials

The two companies bring together cloud-based mobile technologies to improve the identification, screening and matching of patients to precision-based clinical oncology trials RALEIGH, N.C. and COLUMBUS, Ohio, Sept. 18, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) and Deep Lens, Inc., announced today a new strategic relationship to accelerate patient access and recruitment

Secureworks Named a Leader in the IDC MarketScape: Worldwide Managed Security Services (MSS) 2020 Vendor Assessment

Report Highlights Secureworks’ Commitment to Software with Security at its Core ATLANTA, Sept. 18, 2020 (GLOBE NEWSWIRE) — Secureworks® (NASDAQ:SCWX), a leader in software-driven security solutions, today announced it has been recognized as a Leader in the IDC MarketScape: Worldwide Managed Security Services (MSS) 2020 Vendor Assessment.1 The report also recognizes Secureworks’ multi-year strategy to build

Radient Conducts Strategic Review of Operations and Announces Management Changes

EDMONTON, Alberta, Sept. 18, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V:RTI; OTCQX:RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, announces its Board of Directors (the “Board”) is conducting a strategic review of the Company’s operations targeting a path to positive cash flow by evaluating costs and under utilized

Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab for the Treatment of Soft Tissue Sarcoma

3rd Orphan Drug designation for Toripalimab SHANGHAI, China, Sept. 17, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that the U.S. Food and Drug Administration (FDA) has recently granted Orphan Drug designation to Toripalimab for the